Aston Health news

Drawing on the Registry data, the article mainly focuses on CVD epidemiology in the Russian diabetic population over the period 2013-2016.

In September of this year, a number of meetings were held the Ministry of Health where the change in the composition of the drug lists was discussed. Altogether, the designated MoH Committee reviewed around 120 new applications.

On September 26-28, 2018, Moscow will host the IV Eurasian Rheumatology Congress dedicated to the 60^th anniversary of the Institute of Rheumatology and 95^th anniversary of Valentina Nasonova, who pioneered rheumatology in Russia.

Aston Health in conjunction with Endocrinology Research Center conducted a research to find out what drug treatments were commonly used in patients with type 2 diabetes (T2DM) in Russia over the period 2013-2017.

On May 19, 2018, Kaliningrad hosted an “Art of Shaping the Future” conference arranged by Roche (Roche Diagnostics Rus), dedicated to improving of laboratory diagnostics in Russia.

Aston Health in conjunction with Endocrinology Research Center conducted a large-scale study of diabetic coma epidemiology in adult patients with type 1 and type 2 diabetes over the period 2013-2016. The research was ordered by the Ministry of Health.

Aston Health in conjunction with Endocrinology Research Center conducted an epidemiological study of diabetic retinopathy (DR) in Russia. The objective of the research ordered by the Ministry of Health was to explore the incidence of DR in adult patients with type 1 and type 2 diabetes over the period 2013-2016 using the data from the National Registry of Diabetes.

Aston Health in conjunction with Endocrinology Research Center conducted an epidemiological study of chronic kidney disease (CKD) in Russia. The research was ordered by the Ministry of Health.

Aston Health in conjunction with Endocrinology Research Center conducted an epidemiological study of diabetic foot syndrome (DFS) and amputation of lower extremity.

On April 11, in Almaty, Republic of Kazakhstan, Aston Health company held a business breakfast of the cycle "Aston Health Medical programs are effective tools to increase the brand value".

A joint report of Aston Health and the Endocrinology Research Centre, Ministry of Health of Russia, on the meta-analysis of comparative clinical effectiveness and safety of the dipeptidyl peptidase 4-inhibitors and sulfonylureas for the treatment of type II diabetes mellitus was presented at the VIII all-Russian diabetes Congress with international participation "Diabetes mellitus is the pandemia of the XXI century".

During the meeting, Aston staff presented a new analytical PharmCompass Regions

During the VIII All-Russian Diabetes Congress "Diabetes: 21st Century Pandemia", Aston Health and Endocrinology Research Center presented a review of the National Diabetes Registry.

We invite you join us at Business Breakfast ‘Optimisession at Shabolovka’ on March 29, 2018 for interactive presentation PharmCompass Regions: unlimited opportunities for pharma.